Catalyst Pharmaceuticals, Inc. (CPRX) — Analyst outlook / Analyst consensus target is. Based on 16 analyst ratings, the consensus is bullish — 15 Buy, 1 Hold.
The consensus price target is $33.00, representing an upside of 26% from the current price $26.19.
Analysts estimate Earnings Per Share (EPS) of $1.22 and revenue of $0.48B for the next fiscal year.
Earnings Per Share (EPS) track record: 2024: actual $1.38 vs est $1.22 (beat +13.5%). 2025: actual $1.75 vs est $1.61 (beat +8.4%). Analyst accuracy: 90%.
CPRX Stock — 12-Month Price Forecast
$33.00
▲ +26.00% Upside
Average Price Target
Based on 16 Wall Street analysts offering 12-month price targets for Catalyst Pharmaceuticals, Inc., the price target is $33.00.
The average price target represents a +26.00% change from the last price of $26.19.
CPRX Analyst Ratings
Buy
Based on 16 analysts giving stock ratings to Catalyst Pharmaceuticals, Inc. in the past 3 months
EPS Estimates — CPRX
90%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024
Actual $1.38
vs Est $1.22
▲ 11.9% off
2025
Actual $1.75
vs Est $1.61
▲ 7.8% off
Profitability Outlook
Company is profitable with solid earnings. EPS trend is improving.
Revenue Estimates — CPRX
98%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024
Actual $0.492B
vs Est $0.484B
▲ 1.6% off
2025
Actual $0.589B
vs Est $0.579B
▲ 1.7% off
Revenue Trend
Moderate revenue growth trend. Analysts forecast revenue contraction ahead.
